Marie‐Elise Truchetet

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study

Marie Kostine, L. Rouxel, Thomas Barnetche et al. · Annals of the Rheumatic Diseases · 2017 · 302 citations

Life Sciences, Immunology, Oncology +17

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response

C. Jacquemin, Nathalie Schmitt, Cécile Contin‐Bordes et al. · Immunity · 2015 · 223 citations · Full text

Life Sciences, Immunology, Pathobiology +15

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Muriel Elhaï, Marouane Boubaya, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2019 · 188 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease

Marie‐Elise Truchetet, Nicolò Costantino Brembilla, Elisa Montanari et al. · Arthritis Research & Therapy · 2011 · 168 citations · Full text

Life Sciences, Immunology, Pathobiology +17